Aurobindo Pharma to attend ICICI Securities conference on June 8
Aurobindo Pharma Limited officials will participate in the ICICI Securities India Investor Conference on June 8, 2026, in Mumbai. The meeting, scheduled from 10:00 to 18:00 IST, involves in-person and group interactions with investors. The company confirmed that no unpublished price sensitive information will be discussed during the event.
*this image is generated using AI for illustrative purposes only.
Aurobindo Pharma Limited will participate in the ICICI Securities India Investor Conference scheduled for June 8, 2026, in Mumbai, engaging with investors through in-person and group meetings. The interaction is part of the company's routine investor relations activities and provides a platform for management to discuss business performance and strategy. No unpublished price sensitive information (UPSI) is intended to be shared during these discussions, ensuring compliance with regulatory standards.
The meeting is scheduled to occur between 10:00 and 18:00 IST. Officials representing the pharmaceutical major will be present to address queries from attending investors. The company noted that the schedule remains subject to change due to exigencies on the part of the investors or the company itself.
Meeting Details
The following table outlines the key particulars of the scheduled investor interaction:
| Date | Time | Investor/Meeting name | Type of meeting | Location |
|---|---|---|---|---|
| June 8, 2026 | 10:00 to 18:00 (IST) | ICICI Securities India Investor Conference | In-person & Group Meetings | Mumbai |
The disclosure was formally communicated to the exchanges by B. Adi Reddy, Company Secretary of Aurobindo Pharma Limited. The filing was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Aurobindo Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.61% | +1.93% | +5.33% | +21.07% | +27.96% | +51.22% |
What strategic priorities is Aurobindo Pharma likely to emphasize during the investor conference?
How might the discussions influence investor sentiment regarding the company's future growth prospects?
What potential market impacts could arise from the insights shared at the conference?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
